Ondokuz Mayıs Üniversitesi Bilgi Paketi - Ders Kataloğu

Description of Individual Course Units

Course Unit CodeCourse Unit TitleType of CourseYearSemesterECTS
İVFT725 Biotechnology in Pharmacology 927001 1 1 6
Level of Course Unit
Third Cycle
Objectives of the Course
In this course, teaching of importance of biotechnology in pharmacology and properties of biotechnological drugs are aimed.
Name of Lecturer(s)
Prof.Dr. Abdurrahman AKSOY, Assoc.Prof.Dr. Oguzhan YAVUZ, Assoc.Prof.Dr. Yavuz Kürşad DAŞ, Assoc.Prof.Dr. Dilek GÜVENÇ, Assist.Prof.Dr. Enes ATMACA
Learning Outcomes
  1. Knows information about biotechnological applications.
  2. Knows information about pharmaceutic biotechnology.
  3. Knows using of monoclonal antibodies in diagnosis and treatment.
  4. Knows about biotechnological products’ features and usage.
  5. Learns biotechnological products’ pharmaceutic dosage models.
  6. Knows certified and in use biotechnological medicaments.
  7. Knows certified and in use biotechnological medicaments.
Mode of Delivery
Formal Education
Prerequisites and co-requisities
None
Recommended Optional Programme Components
None
Recommended or Required Reading
The Pharmacological Basis of Therapeutics- Goodman and Gilmans, 1985
Basic & Clinical Pharmacology- Bertram G. Katzung, 2000
Planned Learning Activities and Teaching Methods
Language of Instruction
English
Work Placement(s)
None
Course Contents
Biotechnological practices, importance of biotechnology in pharmacology, pharmaceutical biotechnology, monoclonal antibodies and using in diagnosis and therapy, characteristics and using of biotechnological products, pharmaceutical dosing models of biotechnological products, registered and used biotechnological drugs
Weekly Detailed Course Contents
Week Theoretical Practice Laboratory
1.Biotechnological practices
2.Importance of biotechnology in pharmacology
3.Pharmaceutical biotechnology (I)
4.Pharmaceutical biotechnology (II)
5.Monoclonal antibodies and using in diagnosis and therapy (I)
6.Monoclonal antibodies and using in diagnosis and therapy (II)
7.Characteristics and using of biotechnological products (I)
8.MIDTERN EXAM
9.Characteristics and using of biotechnological products (II)
10.Characteristics and using of biotechnological products (III)
11.Pharmaceutical dosing models of biotechnological products (I)
12.Pharmaceutical dosing models of biotechnological products (II)
13.Registered and used biotechnological drugs (I)
14.Registered and used biotechnological drugs (II)
Assessment Methods and Criteria
Term (or Year) Learning ActivitiesQuantityWeight (%)
Midterm Examination1100
SUM100
End Of Term (or Year) Learning ActivitiesQuantityWeight (%)
Final Examination1100
SUM100
Term (or Year) Learning Activities40
End Of Term (or Year) Learning Activities60
SUM100
Workload Calculation
ActivitiesQuantityTime(hours)Total Workload(hours)
Attending Lectures14342
Self Study14570
Individual Study for Mid term Examination11818
Individual Study for Final Examination12020
SUM150